Denosumab in early-stage breast cancer - Authors' reply.

Gnant, Michael

Denosumab in early-stage breast cancer - Authors' reply. [electronic resource] - The Lancet. Oncology 05 2019 - 236 p. digital

Publication Type: Letter; Comment

1474-5488

10.1016/S1470-2045(19)30228-1 doi


Bone Density Conservation Agents
Breast Neoplasms
Denosumab
Disease-Free Survival
Double-Blind Method
Humans
Postmenopause